Medicines and Healthcare products Regulatory Agency

Operation Pangea brings together health regulators, customs authorities, law enforcement agencies, and private sector partners to tackle the threat posed by global criminal networks

The new Business Plan sets out priorities for 2025–26: Protecting public safety and maintaining public trust; delivering efficient, predictable services through regulatory excellence; being an agile organisation that drives innovation; being a great place to work and providing excellent customer service. 

The MHRA will help shape international rules for AI in healthcare – speeding up access to safe, effective technologies into the NHS and worldwide.

MHRA opens second round of applications to test cutting-edge AI medical technologies following successful pilot phase.

As with all products, we will keep its safety under close review

New MHRA CEO puts safety, accelerated access and innovation at the centre of agency’s refreshed strategic direction.

New Post-Market Surveillance (PMS) regulations have taken effect across Great Britain, requiring medical device manufacturers to proactively monitor the safety and performance of their products once on the market.

Patients to benefit from new era in cancer treatment, as Government slashes red tape to unleash life-saving innovation

This is a precautionary measure while the MHRA conducts the safety review.

Anyone who suspects that they’ve had an adverse reaction to their weight loss or diabetes medicine or suspects it is not a genuine product, should report it to the MHRA.